Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Annika Schaefer

2PUBLICATIONS
23CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Mar 02, 2021
Targeting a neoantigen derived from a common <i>TP53</i> mutation.

Emily Han-Chung Hsiue, Katharine M Wright, Jacqueline Douglass

|Mar 02, 2021
Bispecific antibodies targeting mutant <i>RAS</i> neoantigens.

Jacqueline Douglass, Emily Han-Chung Hsiue, Brian J Mog

Pageof 1

Frequent Collaborators

2 joint publications

Jacqueline Douglass

2 joint publications

Emily Han-Chung Hsiue

2 joint publications

Brian J Mog

2 joint publications

Sarah R DiNapoli

2 joint publications

Alexander H Pearlman

2 joint publications

Michelle S Miller

2 joint publications

Katharine M Wright

2 joint publications

P Aitana Azurmendi

2 joint publications

Qing Wang

2 joint publications

Suman Paul

Frequent Collaborators

2 joint publications

Jacqueline Douglass

2 joint publications

Emily Han-Chung Hsiue

2 joint publications

Brian J Mog

2 joint publications

Sarah R DiNapoli

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

7.6K
A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

8.9K
See more related videos

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

7.6K
A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

8.9K
See more related videos